DeepMed Research

Clenbuterol

Generic Name: Clenbuterol

Drug Type: Small Molecule

Chemical Formula: C_₁₂H_₁₈Cl_₂N_₂O

CAS Number: 37148-27-9

Unique Ingredient Identifier: XTZ6AXU7KN

Background: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.

Indication: Used as a bronchodilator in the treatment of asthma patients.

Associated Conditions: Bronchitis, Chronic Obstructive Pulmonary Disease (COPD), Lung Disorder

Clinical Trials

Clenbuterol to Target DUX4 in FSHD

Phase 1

Not yet recruiting

Conditions: Muscular Dystrophy, Facioscapulohumeral

Interventions: Drug: Clenbuterol

First Posted Date: 2024-12-06

Last Posted Date: 2025-03-26

Lead Sponsor: Jeffrey Statland

Target Recruit Count: 30

Registration Number: NCT06721299

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
🇺🇸
University of Washington, Seattle, Washington, United States

A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy

Phase 2

Recruiting

Conditions: Spinal and Bulbar Muscular Atrophy

Interventions: Drug: Clenbuterol
Drug: Placebo

First Posted Date: 2023-12-13

Last Posted Date: 2024-04-15

Lead Sponsor: Gianni Soraru

Target Recruit Count: 90

Registration Number: NCT06169046

Locations: 🇮🇹
Azienda Ospedale Università di Padova, Padova, PD, Italy

Muscle Memory After Treatment With Anabolic Substance Clenbuterol and Resistance Training in Humans

Not Applicable

Recruiting

Conditions: Skeletal Muscle Physiology

Interventions: Drug: Placebo
Drug: Clenbuterol

First Posted Date: 2023-01-20

Last Posted Date: 2023-01-20

Lead Sponsor: Morten Hostrup, PhD

Target Recruit Count: 60

Registration Number: NCT05692856

Locations: 🇩🇰
August Krogh Building, Copenhagen, Denmark

Obese Human Beta-2-adrenergic Stimulation and Muscle Glucose Uptake

Phase 2

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Placebo
Drug: Clenbuterol Hydrochloride

First Posted Date: 2021-06-10

Last Posted Date: 2024-05-07

Lead Sponsor: Maastricht University

Target Recruit Count: 14

Registration Number: NCT04921306

Locations: 🇳🇱
Maastricht University, Maastricht, Netherlands

A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders

Phase 2

Completed

Conditions: Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia

Interventions: Drug: clenbuterol (CST-103), nadolol (CST-107), matching placebo

First Posted Date: 2021-02-04

Last Posted Date: 2024-12-02

Lead Sponsor: CuraSen Therapeutics, Inc.

Target Recruit Count: 41

Registration Number: NCT04739423

Locations: 🇦🇺
The University of Sydney, Sydney, New South Wales, Australia
🇬🇧
MAC, Manchester, United Kingdom
🇳🇿
NZBRI, Christchurch, New Zealand

and more 2 locations

Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis

Phase 2

Completed

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Drug: Clenbuterol

First Posted Date: 2020-01-29

Last Posted Date: 2022-09-06

Lead Sponsor: Dwight Koeberl, M.D., Ph.D.

Target Recruit Count: 25

Registration Number: NCT04245709

Locations: 🇺🇸
Duke University Medical center, Durham, North Carolina, United States

Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease

Phase 2

Withdrawn

Conditions: Pompe Disease (Late-onset)

Interventions: Drug: Placebos
Drug: Clenbuterol

First Posted Date: 2019-09-19

Last Posted Date: 2022-08-17

Lead Sponsor: Duke University

Registration Number: NCT04094948

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Response to Clenbuterol in Humans

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Clenbuterol Oral Product
Drug: Placebo

First Posted Date: 2019-03-04

Last Posted Date: 2024-08-09

Lead Sponsor: University of Copenhagen

Target Recruit Count: 16

Registration Number: NCT03860870

Locations: 🇩🇰
August Krogh Building, Copenhagen, Denmark

Human Beta-2 Adrenergic Stimulation and Muscle Glucose Uptake

Phase 2

Completed

Conditions: Healthy

Interventions: Drug: Clenbuterol Hydrochloride
Drug: Placebos

First Posted Date: 2019-01-11

Last Posted Date: 2022-12-01

Lead Sponsor: Maastricht University

Target Recruit Count: 11

Registration Number: NCT03800290

Locations: 🇳🇱
Maastricht University, Maastricht, Limburg, Netherlands

cAMP Signaling and Muscle Adaptations

Not Applicable

Conditions: Muscle Hypertrophy in Healthy Young Men

Interventions: Other: No training
Other: Endurance training
Drug: Clenbuterol
Other: Resistance Training
Drug: Placebo
Drug: Terbutaline

First Posted Date: 2015-09-23

Last Posted Date: 2017-10-26

Lead Sponsor: University of Copenhagen

Target Recruit Count: 72

Registration Number: NCT02557581

Locations: 🇩🇰
Bispebjerg University Hospital, Copenhagen, Denmark
🇩🇰
Department of Nutrition, Exercise and Sports, Copenhagen, Denmark

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy